Loading resource…

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
The therapeutic landscape for psoriatic arthritis has expanded significantly, introducing various treatment options beyond TNF inhibitors. This document reviews a meta-analysis comparing cycling versus swapping strategies after TNF inhibitor failure, highlighting the need for personalized treatment approaches that consider individual patient characteristics and disease phenotypes. It addresses the challenge of selecting appropriate therapies amidst the growing array of options and the importance of understanding patient-specific factors in treatment decisions.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Repurposing leflunomide and hydroxychloroquine to treat Sjögren's disease (RepurpSS-II): a randomised, double-blind, placebo-controlled, phase 2b trial
Same clinical topic · Rheumatology

EARLY TRAUMA AS THE ORIGIN OF CHRONIC INFLAMMATION: A PSYCHONEUROIMMUNOLOGICAL PERSPECTIVE
Same clinical topic · Rheumatology

IDIOPATHIC INFLAMMATORY MYOPATHIES
Same clinical topic · Rheumatology

MULTIFACTORIAL PATHOGENESIS OF RHEUMATOID ARTHRITIS
Same clinical topic · Rheumatology

SYSTEMIC LUPUS ERYTHEMATOSUS IN CRITICAL CARE: A SYSTEMATIC REVIEW OF ICU OUTCOMES AND MANAGEMENT
Same clinical topic · Rheumatology

RHEUMATOID ARTHRITIS — COMMON ORIGINS, DIVERGENT MECHANISMS
Same clinical topic · Rheumatology

RHEUMATOID ARTHRITIS IN ADULTS
Same clinical topic · Rheumatology

BIOLOGICAL THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS
Same clinical topic · Rheumatology

SYSTEMIC LUPUS ERYTHEMATOSUS: DIAGNOSIS AND TREATMENT
Same clinical topic · Rheumatology